Arrhythmias & electrophysiology

Feasibility of atrial linear ablation using a lattice tip catheter that toggles between radiofrequency and pulsed-field energy under deep sedation

Heart RhythmPublished Retrospective cohort study

Authors' conclusion

This preliminary clinical study demonstrates feasibility and safety of bidirectional block of linear lesions using a lattice tip catheter under deep sedation.

Study context

Population
Patients undergoing atrial fibrillation (AF) ablation including linear lesion ablation for atrial tachyarrhythmia with a lattice tip catheter (radiofrequency/pulsed-field), Germany
Participants
55 patients
Exposure
Linear ablation under deep sedation vs general anesthesia (GA)
  • Deep sedationn = 40
  • GAn = 15reference
Outcome
Bidirectional block of linear lesions
Methodological detailstwo high-volume AF centres
  • Two high-volume AF centres

Main finding

As reported in the abstract

GroupValueLesions blocked
GA21 events21 of 21
Deep sedation97%74 of 76

Value

GA21 events
Deep sedation97%

Lesions blocked

GA21 of 21
Deep sedation74 of 76
  • Deep sedation vs GA: P = 1.000

Observational data: associations, not effects.

Further findings

Bidirectional block by lesion type

Roof line
41 of 41 (100%)
Posterior wall isolation
4 of 4 (100%)
Anterior mitral isthmus line (GA vs deep sedation)
5 of 5 (100%) vs 24 of 25 (96%)
Posterior mitral isthmus line (GA vs deep sedation)
1 of 1 (100%) vs 4 of 5 (80%)
Cavotricuspid isthmus line
15 of 15 (100%)
Left atrial appendage isolation
1

Safety

Overall complications

Overall complication rate (1 cardiac tamponade)
1.8%
Other procedure-related complications
0

Original publication

Feasibility of atrial linear ablation using a lattice tip catheter that toggles between radiofrequency and pulsed-field energy under deep sedation. Heart Rhythm. Published 19 November 2024. doi:10.1016/j.hrthm.2024.11.023

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.